Clinical Trial Update: Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia [NA]

View source ↗

Summary

The clinical trial investigating serum periostin dosage in patients with fibrous dysplasia of bone has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrous Dysplasia of Bone

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Bone Fibrous Dysplasia | NA | Status: COMPLETED